MEDICINES Sans Frontieres has called on Johnson & Johnson to make bedaquiline affordable for people with drug-resistant tuberculosis across the globe.
The charity group was responding to new World Health Organization recommendations for treatment of the condition, including prioritising oral drugs like bedaquiline and minimising the use of injections.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Aug 18
